Prior Auth Required

81413 - KCNH2, KCNJ2, KCNQ1, RYR2, and SCN5A

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / ServiceKCNH2, KCNJ2, KCNQ1, RYR2, and SCN5A
Procedure / Service Description

dosage/deletion analysis (eg, carrier testing), includes SMN2 (survival of motor neuron 2, - catecholaminergic polymorphic ventricular tachycardia); genomic sequence analysis panel, must include sequencing of at least 10 genes, including ANK2, CASQ2, CAV3, KCNE1, KCNE2, 81413 KCNH2, KCNJ2, KCNQ1, RYR2, and SCN5A Cardiac ion channelopathies (eg, Brugada syndrome, long QT syndrome, short QT syndrome, catecholaminergic polymorphic ventricular tachycardia); duplication/deletion gene analysis

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.